A new study reveals some drug combinations may be more beneficial for those with schizophrenia. Researchers found people with schizophrenia who took antidepressants, in combination with other medications, were less likely to be hospitalized for mental health issues than those who started another antipsychotic.
A common antidepressant proves effective in easing agitation associated with Alzheimer's disease, a new study reports.
Researchers report ketamine's antidepressive effects require activation of opioid receptors in the brain. The study highlights the interaction between depression, pain and opioid addiction.
According to researchers, an antidepressant that has been available for more than 50 years could help slow the progression of Parkinson's disease. The drug, nortiptyline, has been shown to stop the growth of alpha synuclein.
The formation of prefrontal cortex dendritic spine formation sustains the remission of depressive related symptoms and behaviors following ketamine treatment by restoring lost spines.
Researchers explain how SSRI antidepressants initiate action by targeting a specific type of nerve cells. Findings may lead to the development of faster acting antidepressants.
The Ph4-tm gene has been implicated in fear and anxiety. P4h-tm knockout mice showed diminished response to fear and showed more courageous behavior than wild-type mice with a functional P4h-tm gene.
Researchers report that a commonly prescribed antidepressant may also protect against compounds that can cause memory loss and dementia.
A new study reports certain nutritional supplements may increase the effectiveness of antidepressants.
The SSRI sertraline (Zoloft), if taken while pregnant, can result in birth defects caused by the drug damaging a cell's genetic information. Researchers report one potential way to counter the effect is with specific antioxidants.